Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jan. 31, 2016	Jan. 31, 2015
Cash flows from operating activities:
Consolidated Net loss	$ (125,292)	$ (1,060,830)
Adjustments to reconcile consolidated net loss to net cash provided by (used in) operating activities
Depreciation and amortization	1,379	1,986
Amortization of Patent Application Costs	2,211	2,379
Loss (Gain) on Change in Value of Derivative Liability	(54,634)	652,348
Interest and Discount on Notes Payable	$ 114,789	152,781
Changes in working capital items:
Accounts receivable		26
Deposits and Prepaid Expenses	$ (3,645)	4,600
Refundable Taxes Receivable	(2,536)	(193)
Accounts Payable and Accrued Expenses	97,789	36,733
Net cash provided by (used in) operating activities	30,061	$ (210,170)
Cash Flows from Investing Activities:
Advances receivable	(283,371)
Net cash used in investing activities	(283,371)
Cash flows from financing activities:
Proceeds from Loan Payable	214,194
Proceeds From Notes Payable	200,000	$ 185,276
Due to Shareholders	(7,279)	$ (3,517)
Issue of Common Shares for Cash	7,279
Net cash provided by financing activities	414,194	$ 181,759
Effects of exchange rate changes on cash	(113,949)	42,355
Net increase in cash and cash equivalents	46,935	13,944
Cash and cash equivalents, beginning of period	49,875	70,676
Cash and cash equivalents, end of period	$ 96,810	$ 84,620